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Introduction
Human Umbilical Cord Matrix Mesenchymal Stem Cells (UC-
MSCs) isolated from Wharton’s jelly show multipotent proper-
ties. They showed higher differentiation potential compared to 
adult Mesenchymal Stem Cells (MSCs). These cells can express 
a low level of  major histocompatibility complex antigens (class 
I and II) and have immunomodulatory properties [1]. The po-
tential of  UCMSCs to differentiate into various lineages, such as 
adipocytes, osteocytes, and chondrocytes, self-renewal capacity, 
and high proliferation rate, have been demonstrated [2]. A recent 
study confirmed the highest efficiency and viability of  UCMSCs 
in the fifth and sixth passages in comparison to other sources, 
such as umbilical cord blood and bone marrow. UCMSCs can be 
considered as a non-invasive, easily available cell source and an 
excellent candidate for cell therapy at end stage liver disease [1, 3]. 
Various in vitro differentiation protocols and subsequent cellular 
therapies need a sufficient source of  viable stem cells with the 
capacity to be functional. UCMSCs have been detected to express 
both embryonic and adult MSC markers [4]. They can also ex-
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press several early hepatic markers, such as albumin, alpha feto-
protein (AFP), and cytokeratin-19 (CK-19), mid and late hepatic 
markers, such as  glucose 6 phosphatase (G6P), connexin 32, and 
CK-18 [5, 6] and a low level of  hematopoietic markers, such as c-
kit and phosphoenolpyruvate carboxykinase (PEPCK) [7]. Based 
on these investigations, UCMSCs demonstrated an intermediate 
phenotype between the hepatoblast and the mature hepatocyte; 
because, the late hepatic markers, including Cytochrome P450 
2B6 (CYP2B6), Hepatocyte paraffin 1 (HepPar1), and Tyrosine 
Amino Transferase (TAT), have not been reported yet to be ex-
pressed by UCMSCs [8]. A lot of  investigations have shown the 
differentiation potential of  MSCs from various sources toward 
hepatocytes [9, 10]. For instance, liver specific genes, such as AFP 
and albumin have been shown to be expressed by rat bone mar-
row-derived MSCs after 21 days of  incubation in the hepatogenic 
medium. Hepatocyte Growth Factor (HGF) is the decisive factor 
and induces the expression of  c-met, the HGF receptor, in the 
target cells [11]. In vitro studies have revealed that HGF induced 
the expression of  liver specific genes (albumin, CK) in human 
mononuclear cord blood cell culture [12]. FGF-4 has mitogenic 
and angiogenic effects and can induce MSCs to proliferate and 
differentiate toward endoderm and subsequently hepatogenic fate 
[13]. Moreover, it has been demonstrated that a combination of  
Fibroblast Growth Factor-4 (FGF4) and HGF could induce bone 
marrow-derived MSCs into functional hepatocyte-like cells [14]. 
During the initiation step of  in vitro hepatocyte differentiation, 
FGF4 is a necessary growth factor for induction of  cells toward 
definitive endoderm and exerts mitogenic and angiogenic effects 
[15].
Most of  the investigations on transdifferentiation of  adult stem 
cells toward hepatic lineage have focused on 2D monolayer cul-
ture system. Cell-cell contact plays a critical role in 3D tissue fab-
rication, such as liver [6]. Culturing the stem cells in a 3D collagen 
scaffold mimics in vivo cytoarchitecture and provides an appropri-
ate microenvironment for cell-cell interaction as well as cell mi-
gration and improves tissue organization [16]. The functions and 
stability of  the hepatocyte phenotype can be improved during the 
differentiation in 3D multicellular aggregates compared to mon-
olayer cultures [17].
Several studies have shown that human UCMSCs had the ability 
to differentiate into hepatocyte-like cells; however, the differenti-
ated cells were not functional [18]. A previous study demonstrat-
ed that the combination of  Insulin like Growth Factor-1(IGF-1) 
with HGF could improve the differentiation of  MSCs toward 
hepatocytes [19]. Therefore, designing an effective, simple, and 
innovative method to produce functional hepatocyte-like cells 
seems to be necessary. The present study aims to evaluate the 
ability of  human UCMSCs as an accessible and feasible source to 
differentiate toward hepatocyte-like cells by a 3D culture system 
in the presence of  hepatogenic media containing IGF-1 with or 
without FGF4.
Materials and Methods
Primary Culture of  UCMSCs
Human umbilical cords were obtained from newborns delivered 
through cesarean sections after obtaining written informed con-
sent from their parents. They were transferred to the laboratory in 
cold Phosphate-Buffered Saline (PBS) containing 100U/mL pen-
icillin, 100 μg/mL streptomycin (Sigma Aldrich, UK). Afterwards, 
the two arteries were removed completely, the umbilical vein was 
cut open, and the endothelia were crushed using a sterile blade. 
Then, the umbilical cords were cut into small pieces, about 5 mm, 
and the explants were put in the culture dishes. After 15 min, 
α-MEM (Gibco BRL, life technology, Germany) containing 10% 
Fetal Bovine Serum (FBS) (Gibco BRL), 1% L-glutamine (Sigma 
Aldrich, UK), and 100U/mL penicillin, 100 μg/mL streptomycin 
were added to the culture plates.
Surface Marker Characterization
The cells were harvested at the third passage and the cell suspen-
sion was adjusted at a concentration of  1×106 cells/mL in cold 
PBS containing 10% FBS as the blocking solution for 20 min. Af-
ter that, the cells were incubated in FITC-conjugated anti-CD44 
and CD144, phycoerythrin–conjugated anti-CD34 and CD106, 
and PerCP-conjugated anti- CD105 antibodies (all from Abcam, 
UK) for 30 min. Then, the cells were washed and resuspended in 
PBS containing 10% FBS. The frequencies of  positive cells were 
evaluated by a FACS calibrated instrument (BD, USA).
Osteogenic and Adipogenic Differentiation Potential of  
UCMSCs
The cells were cultured in the presence of  osteogenic (MACS, 
Germany) and adipogenic media (StemCell Technologies Inc, 
Canada) for 4 and 3 weeks, respectively. The media were changed 
twice a week. After 4 weeks, the differentiated cells in the osteo-
genic medium were fixed in 4% formaldehyde and stained with 
Alizarin red/S. The cells cultured in the presence of  adipogenic 
differentiation medium were fixed at 96% methanol and stained 
by oil red. Images were captured using Nikon Eclipse TE2000-U 
inverted microscope (Nikon, Japan).
Hepatocyte Differentiation
Rat tail type I collagen (Gibco, A10483-01) was prepared accord-
ing to the protocol with some modification just before use [26]. 
Collagen solution at the concentration of  3mg/mL was recon-
structed with 10X DMEM (Gibco BRL) at 8:1 ratio on ice by 
slow and gentle pipetting. The color of  DMEM changed from red 
to yellow, indicating the acidic pH of  the collagen solution. Whar-
ton's jelly-derived MSCs were harvested at passage 4 or 5 and an 
aliquot of  the cells at a density of  7×105 cell/mL with 1mg/mL 
collagen at 1:1 v/v ratio was prepared. The cells were incubated 
at 37°C for 1 h to form collagen gel. Then, the culture medium 
containing 10% FBS was added.
In this study, the 3D cultured-cells were used in 3 different groups. 
The first group that was incubated in DMEM (low glucose) sup-
plemented with 5% FBS, 100 U/mL penicillin, 100μg/mL strep-
tomycin was considered as the control group.
The second group was cultured in hepatogenic medium contain-
ing DMEM supplemented with 5% FBS, 20ng/mL HGF, 20ng/
mL IGF-I (both from Peprotech, UK), 100nM dexamethasone 
(Sigma-Aldrich, UK), 100U/mL penicillin and 100μg/mL strep-
tomycin for 7 days. Afterwards, 10ng/mL oncostatin M (OSM) 
(Peprotech, UK) was also added to the hepatocyte differentiation 
medium for 2 weeks.
The third group was first incubated with DMEM supplemented 
with 5% FBS and 10ng/mL FGF4 (Peprotech, UK) for 2 days. 
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Then, the culture medium was replaced with hepatogenic me-
dium containing DMEM supplemented with 5% FBS, 20ng/mL 
HGF, 100nM dexamethasone, 100 μg/mL penicillin, and 100 U/
mL streptomycin for an additional 5 days. The differentiation pro-
tocol was continued by adding 10 ng/mL OSM (Figure 1). In all 
the groups, the cultures were continued for 21 days and half  of  
the culture media was changed every 3 days.
Real Time RT-PCR Analysis
Total RNA was extracted from UCMSCs by Biazol isolation rea-
gent (Bioflux, Japan) according to the manufacturer’s instructions. 
The concentration and purity of  the extracted RNA were deter-
mined by Biophotometer (Eppendorf, Germany). Then, total 
RNA (5µg) was subjected to Reverse Transcription Polymerase 
Chain Reaction (RT-PCR) to make cDNA. The cDNA (2 μl) was 
used as the template for real-time PCR reactions. The primers 
were designed using Primer-BLAST online program based on the 
human DNA sequences found in the genebank [20] (Table 1). 
Real-time PCR was performed using the SYBRs Green PCR Mas-
ter Mix (Applied Biosystems, USA) in 50 cycles with an initial de-
naturation temperature of  95°C for 10 min continued by cycling 
denaturation in 95°C for 15 seconds, annealing at 60°C for 1 min. 
After amplification, melting curve analyses were performed to en-
sure that no primer-dimers were produced, confirming the accu-
racy of  the reactions. The accuracy of  the reactions was checked 
by gel electrophoresis of  PCR products. The cDNA of  HepG2 
cell line was used as the positive control.
Normalization of  target gene expression levels was performed 
using 18S as a housekeeping gene. Besides, the following formula 
was used for computation of  Relative Quantification (RQ): 2-∆∆Ct.
Immunohistochemical Staining
After washing with PBS, collagen gels were immersed in Bouin’s 
fixative, embedded in paraffin, cut into 10-μm thick sections, and 
mounted on glass slides. The sections were deparaffinized in xy-
lene (Sigma, UK), rehydrated in ethanol, and rinsed in PBS. The 
slides were incubated in 3% H2O2 (Sigma, UK) to suppress the 
endogenous peroxidase activity for 20 min. The standard heat-
mediated citrate buffer antigen retrieval protocol was used for 
Figure 1. Schematic diagram of  the protocol steps for each experimental group.
Control
-FGF4
+FGF4
0 day        2nd              7th day 21st day
HGF, IGF, Dex HGF, IGF, Dex and OSM
FGF4 HGF, IGF, Dex HGF, IGF, Dex and OSM
Table 1. The primer sequences used for Quantities real time PCR
Primer sequence Size (base pair)
Albumin 5’-ACAGAGACTCAAGTGTGCCAGT-3’ 198bp
5’-GCAAGGTCCGCCCTGTCATC-3’
Alpha-fetoprotein 5’-TTCATATGCCAACAGGAGGC-3’ 152 bp
5’-TGAGAAACTCTTGCTTCATCGT-3’
Cytokeratin-18 5’-AAATCCGGGAGCACTTGGAG-3’ 132 bp
5’-CAATCTGCAGAACGATGCGG-3
Cytokeratin-19 5’-ACTACACGACCATCCAGGAC-3’ 126 bp
5’-CCGTCTCAAACTTGGTTCGGA-3
CYP2B6 5’-TTCTTCCGGGGATATGGTGT-3’ 91 bp
5’-TCCCGAAGTCCCTCATAGTG-3’
Hepatic Nuclear Factor 4 5’-AAGAAATGCTTCCGGGCTGG-3’ 156bp
5’-GACGGGGGAGGTGATCTGTC-3’
Glucose-6-phosphatase 5’-CGACGAAGCGCAGACAG-3’ 113bp
5’-GTATCCGACTGATGGAAGGC-3’
Claudin 5’-CTTCTTGCAGGTCTGGCTAT-3’ 196bp
5’-AGGTTGTTTTTCGGGGACAG-3’
18S 5’-GTTGATTAAGTCCCTGCCCT-3’ 75bp
5’-TCCGAGGGCCTCACTAAACC-3’
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anti-CK18 and -AFP antibodies. The sections stained for CK19 
were incubated with proteinase K (Sigma Adrich, UK). Then, the 
slides were washed with PBS for three times and incubated with 
PBS containing 10% goat serum to block non-specific binding 
sites for 20 min. Then, primary anti-CK18, 19 antibodies and 
AFP (1:100 dilution, Abcam, UK) were added to the slides at 
4°C overnight in a humidified dark chamber. Negative controls 
were performed by omitting the primary antibodies. The slides 
were washed in PBS 2X for 10 min. After that, they were incu-
bated in Super Enhancer for 15 min and then in Polymer_HRP 
(Envision) for 30 min. Fresh prepared-diaminobenzidine (DAB) 
(Sigma, UK) solution containing H2O2 was added to the slides 
for 3 min and DAB was removed by rinsing the slides in distilled 
water. After all, the slides were counterstained with hematoxylin, 
dehydrated, and mounted.
Immunofluorescence
For immunofluorescence staining of  3D culture cells, the slides 
were deparafinized in xylene, rehydrated in ethanol and rinsed in 
distilled water. The slides were permeabilized with 0.5% Triton 
X-100 (Sigma, UK)  for 10 min and blocked with 10 % goat serum 
in PBS for 20 min. The sections were incubated with 1:100 dilu-
tions of  anti-albumin FITC-conjugated (Abcam, UK) at dark for 
1h. After washing with PBS for 3 times, the slides were counter-
stained with DAPI (Sigma, UK), washed with PBS and analyzed 
by the fluorescence microscope (Olympus, BX51, and Japan).
Periodic Acid Schiff  (PAS) Assay
The 3D culture sections were deparaffinized and oxidized in 
1% periodic acid for 5 minutes. Sections were then incubated in 
Schiff  reagent for 15 min, and washed in running tap water for 
5-10 min. The sections were then dehydrated and mounted.
Indocyanine Green Test
The cells were exposed to 1 mg/mL Indocyanine green (ICG) 
(Cardiogreen; Sigma Aldrich, UK) at 5% CO2 at 37°C for 1h. The 
cells were then washed with PBS for three times. After that, they 
were incubated with fresh William's medium containing 10% FBS 
for 6 h. The medium was collected and the concentration of  ICG 
released from the cells was determined at an optical density of  
820 nm by spectrophotometer analyses (Cecil 1011, UK) [21].
Statistical Analysis
All the statistical analyses were performed using GraphPad Prism 
5 software (GraphPad, USA) and Mann-Whitney test. P-value 
<0.05 was considered as statistically significant.
All the experiments were performed in triplicate.
Results
Characterization of  UCMSCs
Flow cytometry data showed that UCMSCs were positive for the 
common MSCs surface markers, such as CD90 (94.5%), CD73 
(98.5%), CD44 (92.7%), CD105 (77.2%), and CD106 (43.5%) and 
the reaction was negligible for hematopoietic stem cell (CD34, 
1.06%) and endothelial cell (CD144, 2.06%) markers (Figure. 2). 
The osteogenic and adipogenic capacities of  these cells were eval-
Figure 2. The flow cytometry showed the frequency of  the umbilical cord mesenchymal stem cells which reacted to CD90, 
CD73, CD44, 105, and 106; however, the frequency of  the cells which reacted to CD 34 and 144  was negligible.
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uated by alizarin red S and oil red staining, respectively (Figure. 3). 
These results confirmed the multipotency of  the UCMSCs.
Cell Morphology
The primary cells in the conventional culture condition showed 
a fibroblast-like morphology which is a typical characteristic of  
MSCs. The morphology of  UCMSCs was also spindle or star 
shape; however, the morphology of  the cells treated with hepa-
togenic media was changed into a round shape after supplemen-
tation of  the culture media with OSM (Figure. 4). Also, some 
cells had a tendency toward enclosing a luminar space in the 3D 
scaffolds. Human UCMSCs were proliferated more rapidly in re-
sponse to the growth factors presented in the hepatogenic media; 
in such a way that the density of  the cells was higher in the growth 
factor-treated cultures compared to the control cultures.
Real Time PCR
The expression profiles of  albumin, AFP, CK18, CK19, and 
CYP2B6 mRNA were evaluated in the cultured cells in all the 
groups after 21 days. A low level of  liver-specific genes was also 
expressed by the human UCMSCs which were cultured in a con-
dition without any hepatogenic differentiation factors (control 
cultures).
Similarly, these genes were detected in the cells cultured in hepa-
togenic media supplemented with or without FGF4. The hepato-
genic media supplemented with FGF4 induced the cells to express 
a non-significant higher level of  these early and mid-stage hepatic 
markers including albumin, AFP, CK18, CK19, HNF4-α, and  a 
significant higher level of  CYP2B6 (180~, 44~, 4~, 12.6~, 29.6~ 
and 21000~fold, respectively) than the control cultures. A very 
low level of  the CYP2B6 mRNA expression was also detected in 
undifferentiated UCMSCs. The cells in control cultures could ex-
press more claudin compared with the cells exposed to the hepa-
togenic media (Figure. 5). In the cultures exposed to hepatogenic 
media without FGF4, albumin, HNF4-α and AFP were expressed 
27.3~, 17~ and 16~ fold higher than control cultures, respec-
tively. However, the quantity of  the CK18 and 19 did not change 
after treatment of  the cells with hepatogenic media. The expres-
sion of  G6P was decreased in the cells exposed to hepatogenic 
factors with or without FGF4. The statistical analyses did not 
show any significant difference between the three groups except 
for CYP2B6 (P=.02). After gel running, the band of  the PCR 
product was formed at the appropriate position (data not shown).
Immunohistochemistry and Immunofluorescence
Immunohistochemistry staining of  the differentiated UCMSCs 
revealed the expression of  AFP, CK-18, and CK-19 (Figure. 6) 
in different cultures. The expression of  the early hepatogenic 
markers was low in 3D scaffolds in the absence of  hepatogenic 
media after 10 days of  culturing. The percentages of  the positive 
cells for CK18, 19, and AFP are summarized in Table 2. In order 
to find the impacts of  long term culture of  the UCMSCs in 3D 
condition on the level of  the gene expression, the current study 
compared the expression of  the hepatocyte-specific markers in 
long term (21 days) with short term cultures (10 days). Although 
the UCMSCs' morphology did not change in the control cultures, 
the results showed a significant increase in the intensity of  the 
reactions to various antibodies and besides, the frequency of  the 
AFP-positive cells in the cells cultured within a 3D collagen scaf-
fold for long-term (21 days) was increased compared to those 
cultured for a short period of  time (P=0.013). The cells which 
were exposed to hepatogenic media with or without FGF4 also 
expressed early hepatogenic markers along with cell morphology 
modification. These cells showed a significant increase in CK19 
and AFP expression compared to the control groups (P=0.0001 
and P=0.0001). Moreover, the frequency of  the CK18 increased 
significantly after pre-exposure of  the cells to FGF4 compared 
to the cultures treated with just hepatogenic medium (P=0.012), 
control cells cultured for 10 days (P=0.003), and control cells cul-
tured for 21 days without passages (P=0.001).
Immunofluorescence staining of  the differentiated HUCMSCs 
revealed the expression of  Albumin in 3D culture conditions 
(Figure. 7). The results showed an increase in the intensity of  the 
reactions to albumin in the cells cultured within a 3D collagen 
scaffold for long-term (21 days) compared to those cultured for a 
short period of  time (10 days). Albumin was detected in the cells 
which were exposed to hepatogenic media with or without FGF4. 
No changes were detected in the comparison of  different groups.
Functional Assay
The glycogen storage capacity of  the UCMSCs was evaluated by 
PAS staining. The non-treated UCMSCs which were cultured for 
Figure 3. Alizarin red/S staining revealed Ca+ deposition in the cells cultured in osteogenic medium (a) and its absence in 
the control cultures (b). Oil red O revealed the presence of  lipid droplets in the cells cultured in adipogenic medium (c) and 
its absence in the control cultures (d).
a b
c d
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Figure 4. The inverted microscopy of  the cells cultured in 3D collagen scaffold showed that the cell morphology was 
changed in the cultures exposed to hepatogenic media with (a) or without FGF4 (b) compared to the control culture (c). 
The nucleus was counterstained with hematoxylin.
a b c
Figure 5. Real time analysis of  the expression level of  liver-specific markers in HUCMSCs cultured in DMEM (control) in 
the hepatogenic media with or without FGF4. The cells exposed to FGF4 showed a higher expression level of  liver-specific 
genes, except for claudin and G6P compared to the hepatogenic-treated and control cultures.
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Figure 6. The immunocytochemistry showed low expression of  cytokeratin 19, 18 and alpha-fetoprotin in the umbilical cord 
mesenchymal stem cells cultured for 10 days without passaging (a-c). Long-term culturing the cells led the cells to express 
cytokeratin 19, 18 and alpha-fetoprotein at a higher level; however, the cells showed a fibroblast-like morphology (d-f). The 
cells exposed to the hepatogenic media with or without FGF4 also expressed a high level of  this protein (g-l). Some cells ex-
posed to hepatogenic media came together and formed a tubular structure (k). These cells also were positive for cytokeratin 
19. The rest of  the cells revealed round shape morphology after treatment with hepatogenic media (g-l).
a
b
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e
f
g
h
i
j
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l
Cytokeratin 18
Cytokeratin 19
Alpha fetoprotein
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10 days without passage showed a low level of  glycogen stor-
age (24%). However, long-term cultured cells (for 21 days) (70%) 
demonstrated the ability to store glycogen. The hepatogenic me-
dia with (78%) or without (73%) FGF4 also induced the UCMSCs 
to show a “strong” positive reaction to PAS staining (Figure 8).
Indocyanine Green (ICG) Uptake
The cellular uptake and release of  ICG were assessed in the dif-
ferentiated and undifferentiated cells in 3D culture systems on 
day 21. The statistical analyses showed a significant increase in the 
ICG released by the cells incubated in hepatogenic media with or 
without FGF4 (P=0.029) compared to the control group. How-
ever, no significant difference was observed in ICG elimination 
after supplementation of  the culture medium with FGF4 com-
pared to the hepatogenic-treated cells without FGF4. Further-
more, keeping the cells in 3D collagen scaffold for long term led 
to a non-significant increase in ICG elimination in comparison to 
the controls (Figure 9).
Discussion
Human UCMSCs showed a hepatogenic potential and could con-
sequently be used as an important source in treatment of  many 
liver diseases. Moreover, they could express a combination of  
several early and mid-hepatic markers, such as AFP, CK-18, and 
CK-19. Our findings showed a low level of  liver-specific mRNA 
expression in the UCMSCs cultured for long-term without any 
hepatogenic supplementation, which was in agreement with the 
findings of  a previous research [8]. The results of  immunohis-
tochemistry showed that the intensity of  the reactions to liver-
specific markers increased after long-term culturing in 3D colla-
gen scaffold. Thus, it can be suggested that the cells release some 
cytokines which are responsible for accelerating the expression of  
liver-specific markers [8]. This growth factor can induce the cells 
to express liver-specific markers, such as albumin and CKs [8, 12]. 
Despite the expression of  liver-specific markers, no change was 
observed in the cell morphology in the absence of  hepatogenic 
media. These results, along with the findings of  other researchers, 
showed that these cells had a native potential to express liver-
specific genes and might be one of  the best cell source for dif-
ferentiation into hepatocytes [3, 8].
The supplementation of  the culture media with hepatogenic fac-
tors containing HGF induces the cells to change their morphol-
ogy. Moreover, hepatocyte growth factor induces the signaling 
pathway which is responsible for cell proliferation and organ 
morphogenesis during liver development [19]. Hepatogenic me-
dium was shown to induce human umbilical cord blood MSCs 
to change into the small, round, and epithelioid shape [14]. The 
density of  the cells in 3D cultures also increased in the presence 
of  hepatogenic media. Both HGF and FGF4 exert a mitogenic 
Table 2. the mean of  the percent and standard deviation of  the reacted-cells to the cytokeratin 18, 19 and alpha fetoprotein 
antibodies.
Liver specific 
markers
Control (21 days)
(mean ± SD)
Control (10 days)
(mean ± SD)
Without FGF4 
(mean ± SD)
With FGF4 
(mean ± SD)
Cytokeratin 18 34.34±5.19 42.15±1.36 48.36±5.86 69.11±0.54*
Cytokeratin 19 30.63±3.32 35.7±7.07 71.76±3.88* 63.96±1.95*
Alpha-fetoprotein 40.50±1.06£ 23.50±3.99 60.01±4.67¥ 64.80±4.45¥
* Significant difference with all other groups (P<0.05)
¥ Significant difference with two control groups (P<0.05)
£ Significant difference with control (10 days) (P<0.05)
Figure 7. Immunofluorescence micrographs showed that HUCMSCs expressed albumin in the presence or absence of  
hepatogenic media in 3D culture scaffold and pre-treated cultures with or without FGF4. There was no change between 
groups.
Control 10 day
Control 21 day
With FGF4
Without FGF4
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activity which might be the reason for the higher cell density ob-
served in the cultures treated with hepatogenic media [15].
IGF-1 has been shown to induce Embryonic Stem Cells (ESC) to 
differentiate toward hepatogenic lineage [22]. IGF-I also plays a 
role in liver development and regeneration and it has been dem-
onstrated to be released in the damaged liver. In addition, it can 
exert a mitogenic activity and stimulate the secretion of  HGF 
[19] as well as albumin [23]. A combination of  IGF-1with HGF, 
dexamethasone, and OSM were used to induce adipose-derived 
MSCs toward hepatogenic lineage [19]. FGF4 is a cytokine which 
induces cell differentiation toward definitive endoderm in vitro. 
FGF4 has been used in hepatogenic protocols for differentiation 
of  various stem cells, such as human MSCs derived from cord 
blood [14], and human UCMSCs [18], in 2D culture condition. It 
has been demonstrated that a combination of  FGF4 and HGF 
could induce bone marrow-derived MSCs into functional hepato-
cyte-like cells [14]. The data from the present study revealed G6P 
gene was expressed at a non-significant higher level in the con-
trol cultured in 3D collagen scaffold compared with the cells ex-
posed to hepatogenic media. A recent study showed that the adult 
hepatocytes cultured in the medium containing insulin and Dexa 
express a lower level G6P. The insulin exerted this inhibitory ef-
fect by acting on response sequence (IRS) in the promoter region 
of  the Glc-6-Pase gene [24]. The mRNA expression of  endoder-
mal and hepatocyte-specific genes was evaluated at varying stages 
of  human ESC differentiation. The differentiated human ESCs 
demonstrated typical ultrastructural features of  hepatocytes [25].
A 29.6 - fold increase in the expression of  HNF-4α, as the main 
hepatocyte gene, was showed in the cell differentiated into hepat-
ocyte-like cells; however, it was non-significant. The investigations 
demonstrated that FGFs can induce the HESCs to achieve the 
ability of  HNF-4α expression [26]. The results demonstrated that 
both FGF4 and 3D collagen scaffold can be useful for increasing 
the expression level of  mid and late hepatogenic factors such as 
albumin, AFP, CK18, CK19, CYP2B6 and HNF4-α. Besides, real 
time RT-PCR showed that naïve UCMSCs expressed a non-signif-
icant high level of  claudin when cultured in 3D collagen scaffold. 
In fact, the expression of  claudin is not limited to hepatocytes. 
Any mesenchymal-epithelial transition is accompanied by an in-
crease in claudin expression [27]. Mesenchymal-epithelial tran-
sition may occur in non-treated UCMSCs and may lead to the 
expression of  the tight junction specific marker, claudin. For in-
stance, MSCs secrete Vascular Endothelial Growth Factor which 
may induce the cells toward endothelial cell lineage through an au-
tocrine signaling pathway [9]. In the present study, the functional 
assays also showed that all the cultures treated with or without 
FGF4 could store glycogen and eliminate ICG. The same amount 
of  ICG uptake and elimination was detected in both experimental 
cultures; however, they released a significant higher concentration 
of  ICG compared to control cultures.
Figure 8. The PAS assay showed that the umbilical cord mesenchymal stem cells cultured for 10 days without passaging 
could not store a large amount of  glycogen (a). Long-term culturing the cells led to an increase in glycogen synthesis; 
however, the cells showed a fibroblast-like morphology (b). The cells exposed to the hepatogenic media with or without 
FGF4 also reacted to PAS staining “strongly” (c and d). Some cells exposed to hepatogenic media with FGF4 come together 
and formed a tubular structure (c). These cells also stored glycogen. The rest of  the cells revealed round shape morphology 
after treatment with hepatogenic media. The cells density was higher in the growth factor-treated cultures.
a b
c d
Figure 9. The comparison of  the optical density of  indocyanine green released from umbilical cord mesenchymal stem cells 
cultured in DMEM (controls) in the presence of  hepatogenic media with or without FGF4 for 2 and 21 days. 
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One study assessed the efficiency of  nanofibers collagen scaffold 
prepared by electrospun on hepatogenic potential of  the human 
bone marrow derived-MSCs and the results indicated a higher 
liver-specific marker expression [28]. 3D culture in collagen 
scaffold led to an increase in expression of  liver specific mark-
ers compared to 2D culture condition. 3D culture condition also 
improved the hepatocyte phenotype [29]. This study also showed 
that some cells were arranged in a tubular shape, while some oth-
ers were scattered throughout the scaffold in 3D culture condi-
tion. The tubular structure showed a positive reaction to CK19. It 
has also been demonstrated that CK19 was expressed by bile duct 
epithelial cells [30].
Conclusion
In conclusion long-term culturing of  UCMSCs in 3D environ-
ment could induce the cells to express a higher level of  hepato-
genic markers at protein level and also they became functional, 
as well. Therefore, it seems that UCMSCs showed a tendency to 
differentiate into hepatocyte-like cells after culturing for a long 
period of  time without passaging. Moreover, pre-treatment of  the 
cells with FGF4 before exposure to hepatogenic medium con-
taining IGF-1 and HGF could improve the expression of  some 
late liver-specific markers in mRNA level such as CYP2B6.
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